Skip to main content
Top
Published in: Pathology & Oncology Research 1/2014

01-01-2014 | Research

MCM3 Protein Expression in Follicular and Classical Variants of Papillary Thyroid Carcinoma

Authors: Yusuf Ziya Igci, Suna Erkilic, Mehri Igci, Ahmet Arslan

Published in: Pathology & Oncology Research | Issue 1/2014

Login to get access

Abstract

Minichromosome maintenance (MCM) proteins are needed as licensors in the DNA replication of eukaryotic cells and transcriptional control of MCM genes has critical role in the regulation of MCM functions. Different MCM protein family members are proposed as diagnostic or prognostic markers in various cancers due to their increased proliferative potential. Among MCM family members, minichromosome maintenance protein 3 (MCM3) expressions in both mRNA and protein levels were shown to be associated with papillary thyroid carcinoma (PTC). But, the usability of MCM3 in some histological variants of PTC might be controversial due to tissue specific molecular heterogeneities. In follicular variant of papillary thyroid carcinoma (FVPTC), a number of genes including MCM3 were shown to be differentially expressed which were specific to this kind of variant. Using immunohistochemistry method, MCM3 protein expression levels were compared in FVPTC, classic variant of papillary thyroid carcinoma (CVPTC), and multi-nodular goiter (MNG) tissues in a group of 32 cases. There was meaningful differences between MNG vs. FVPTC (p = 0.016) and MNG vs. CVPTC (p = 0.019) while there was no significant difference in the comparison FVPTC vs. CVPTC (p = 0.15). Four of the 5 CVPTC cases having surrounding tissue invasion had high expression values. For FVPTC and CVPTC, MCM3 protein expression results were parallel to our previous mRNA expression study while there was downregulation in protein expression despite the increased expression of MCM3 mRNA in MNG suggesting tissue-specific post-transcriptional events in benign thyroid neoplasms of which should be focused on. Moreover, the relatively lower MCM3 protein expression in FVPTC comparing to CVPTC could be due to a different tumorigenic pathway favored in this type of tissue.
Literature
1.
2.
go back to reference Fagin JA, Mitsiades N (2008) Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab 22:955–969PubMedCentralPubMedCrossRef Fagin JA, Mitsiades N (2008) Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab 22:955–969PubMedCentralPubMedCrossRef
3.
go back to reference Erickson L, Lloyd R (2010) Well-differentiated papillary thyroid carcinoma. In: Hunt J (ed) Molecular pathology of endocrine diseases. Springer, New York, pp 57–71CrossRef Erickson L, Lloyd R (2010) Well-differentiated papillary thyroid carcinoma. In: Hunt J (ed) Molecular pathology of endocrine diseases. Springer, New York, pp 57–71CrossRef
4.
go back to reference Ertek S, Yilmaz NC, Cicero AF, Vurupalmaz O, Demiroz AS, Erdogan G (2012) Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers. Endocr Pathol 23:157–160PubMedCrossRef Ertek S, Yilmaz NC, Cicero AF, Vurupalmaz O, Demiroz AS, Erdogan G (2012) Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers. Endocr Pathol 23:157–160PubMedCrossRef
5.
go back to reference Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA (2006) Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255–1264PubMedCrossRef Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA (2006) Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255–1264PubMedCrossRef
7.
go back to reference Salajegheh A, Petcu EB, Smith RA, Lam AK (2008) Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med J 84:78–82PubMedCrossRef Salajegheh A, Petcu EB, Smith RA, Lam AK (2008) Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med J 84:78–82PubMedCrossRef
8.
go back to reference Igci YZ, Arslan A, Akarsu E, Erkilic S, Igci M, Oztuzcu S, Cengiz B, Gogebakan B, Cakmak EA, Demiryurek AT (2011) Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma. Endocr Pathol 22:86–96PubMedCrossRef Igci YZ, Arslan A, Akarsu E, Erkilic S, Igci M, Oztuzcu S, Cengiz B, Gogebakan B, Cakmak EA, Demiryurek AT (2011) Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma. Endocr Pathol 22:86–96PubMedCrossRef
10.
go back to reference Maine GT, Sinha P, Tye BK (1984) Mutants of S. cerevisiae defective in the maintenance of minichromosomes. Genetics 106:365–385PubMed Maine GT, Sinha P, Tye BK (1984) Mutants of S. cerevisiae defective in the maintenance of minichromosomes. Genetics 106:365–385PubMed
11.
go back to reference Ha SA, Shin SM, Namkoong H, Lee H, Cho GW, Hur SY, Kim TE, Kim JW (2004) Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res 10:8386–8395PubMedCrossRef Ha SA, Shin SM, Namkoong H, Lee H, Cho GW, Hur SY, Kim TE, Kim JW (2004) Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res 10:8386–8395PubMedCrossRef
12.
go back to reference Giaginis C, Vgenopoulou S, Vielh P, Theocharis S (2010) MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol 25:351–370PubMed Giaginis C, Vgenopoulou S, Vielh P, Theocharis S (2010) MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol 25:351–370PubMed
13.
go back to reference Lee YS, Ha SA, Kim HJ, Shin SM, Kim HK, Kim S, Kang CS, Lee KY, Hong OK, Lee SH, Kwon HS, Cha BY, Kim JW (2010) Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma. Exp Mol Pathol 88:138–142PubMedCrossRef Lee YS, Ha SA, Kim HJ, Shin SM, Kim HK, Kim S, Kang CS, Lee KY, Hong OK, Lee SH, Kwon HS, Cha BY, Kim JW (2010) Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma. Exp Mol Pathol 88:138–142PubMedCrossRef
14.
go back to reference Lei M (2005) The MCM complex: its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets 5:365–380PubMedCrossRef Lei M (2005) The MCM complex: its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets 5:365–380PubMedCrossRef
15.
go back to reference Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM (2007) Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Ann Surg Oncol 14:3403–3411PubMedCrossRef Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM (2007) Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Ann Surg Oncol 14:3403–3411PubMedCrossRef
16.
go back to reference Musahl C, Holthoff HP, Lesch R, Knippers R (1998) Stability of the replicative Mcm3 protein in proliferating and differentiating human cells. Exp Cell Res 241:260–264PubMedCrossRef Musahl C, Holthoff HP, Lesch R, Knippers R (1998) Stability of the replicative Mcm3 protein in proliferating and differentiating human cells. Exp Cell Res 241:260–264PubMedCrossRef
17.
go back to reference Endl E, Kausch I, Baack M, Knippers R, Gerdes J, Scholzen T (2001) The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells. J Pathol 195:457–462PubMedCrossRef Endl E, Kausch I, Baack M, Knippers R, Gerdes J, Scholzen T (2001) The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells. J Pathol 195:457–462PubMedCrossRef
18.
go back to reference Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K (2006) Cancer stem cell hypothesis in thyroid cancer. Pathol Int 56:485–489PubMedCrossRef Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K (2006) Cancer stem cell hypothesis in thyroid cancer. Pathol Int 56:485–489PubMedCrossRef
19.
go back to reference Shibru D, Chung KW, Kebebew E (2008) Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol 20:13–18PubMedCrossRef Shibru D, Chung KW, Kebebew E (2008) Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol 20:13–18PubMedCrossRef
20.
go back to reference Salabe GB (2001) Pathogenesis of thyroid nodules: histological classification? Biomed Pharmacother 55:39–53PubMedCrossRef Salabe GB (2001) Pathogenesis of thyroid nodules: histological classification? Biomed Pharmacother 55:39–53PubMedCrossRef
21.
go back to reference Madine MA, Swietlik M, Pelizon C, Romanowski P, Mills AD, Laskey RA (2000) The roles of the MCM, ORC, and Cdc6 proteins in determining the replication. J Struct Biol 129:198–210PubMedCrossRef Madine MA, Swietlik M, Pelizon C, Romanowski P, Mills AD, Laskey RA (2000) The roles of the MCM, ORC, and Cdc6 proteins in determining the replication. J Struct Biol 129:198–210PubMedCrossRef
22.
go back to reference Zhu M, Wang F, Yan F, Yao PY, Du J, Gao X, Wang X, Wu Q, Ward T, Li J, Kioko S, Hu R, Xie W, Ding X, Yao X (2008) Septin 7 interacts with centromere-associated protein E and is required for its kinetochore localization. J Biol Chem 283:18916–18925PubMedCrossRef Zhu M, Wang F, Yan F, Yao PY, Du J, Gao X, Wang X, Wu Q, Ward T, Li J, Kioko S, Hu R, Xie W, Ding X, Yao X (2008) Septin 7 interacts with centromere-associated protein E and is required for its kinetochore localization. J Biol Chem 283:18916–18925PubMedCrossRef
Metadata
Title
MCM3 Protein Expression in Follicular and Classical Variants of Papillary Thyroid Carcinoma
Authors
Yusuf Ziya Igci
Suna Erkilic
Mehri Igci
Ahmet Arslan
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 1/2014
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-013-9662-9

Other articles of this Issue 1/2014

Pathology & Oncology Research 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine